Tradestie Institutional Equity Comparison Engine
BGMSP vs CVM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CVM Overall Edge
CVM Captures Institutional Edge (3โ1 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cel-Sci Corporation (CVM) driven by superior Valuation, Growth & Margin, Momentum & Technical while BGMSP counters with relative strength in Options & Structure. Fundamentally, BGMSP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CVM at 23.0x Forward P/E and 0.0% operating margin (-62.7% YoY). In options structure, BGMSP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
CVM
BGMSP N/M vs CVM 23.0x Fwd P/E
Growth & Margin Winner
CVM
Op Margin N/A vs 0.0% ยท YoY N/A vs -62.7%
Momentum & Technical Winner
CVM
1Y -72.6% vs -77.5% ยท 52W Pos 0% vs 10%
Options & Structure Winner
BGMSP
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
BGMSP
US Equity
BGMSP
Institutional Equity
$1.44
-39.75% 1D
Market Cap
N/A
1M Return
-60.98%
1Y Return
-72.57%
Forward P/E
N/M
Unified AI Score
42.7 / 100
HOLD
Tech 45.0
Fund 48.0
Flow 50.0
Mom 50.0
CVM
NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap
$20.9M
1M Return
-11.17%
1Y Return
-77.48%
Forward P/E
23.0x
Unified AI Score
56.6 / 100
HOLD
Tech 60.0
Fund 54.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BGMSP -72.57%
CVM -77.48%
Spread: +24.37 pp (CVM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BGMSP TTM Op. Margin: N/A
CVM TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGMSP vs CVM. Trailing 12-month operating profitability (BGMSP N/A vs CVM 0.0%) and valuation multiples (BGMSP N/M vs CVM 23.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BGMSP | CVM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $20.9M | Larger Scale | CVM |
| Trailing P/E Ratio Valuation | N/M | 23.0x | Lower Multiple | CVM |
| Forward P/E Ratio Valuation | N/M | 23.0x | Lower Multiple | CVM |
| Revenue Growth (YoY) Growth | N/A | -62.7% | Higher Growth | CVM |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | CVM |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | CVM |
| Return on Equity (ROE) Capital Efficiency | N/A | -252.5% | Higher ROE | CVM |
| 52-Week Range Position Momentum | 0% ($1โ$14) | 10% ($1โ$8) | Stronger Trend | CVM |
| Beta / 30D Volatility Risk Regime | 0.59ฮฒ ยท 201% Vol | 0.65ฮฒ ยท 120% Vol | Lower Realized Risk | CVM |
| Unified Institutional Score Composite Signal | 42.7 / 100 (HOLD) | 56.6 / 100 (HOLD) | Higher Composite | CVM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BGMSP vs CVM Buy Guide
BGMSP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CVM
BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BGMSP nor CVM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.